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P ercutaneous transluminaJ coronary balloon angio- plasty is now widely accepted as a safe and effec- tive treatment in selected patients with obstructive 
coronary artery disease.’ However, acute vessel closure 
and late restenosis are inherent to balloon angioplasty 
and continue to compromise its efficacy.2,3 Although the 
exact pathophysiologic mechanism(s) and factors respon- 
sible for restenosis are largely unknown, some clinical 
and angiographic variables have been identified as po- 
tential risk factors.4 There is, furthermore, some evi- 
dence that repeat angioplasty of a previously dilated le- 
sion in a native coronary artery is associated with a 
higher incidence of restenosiss9 The Wiktor stent has 
been used to treat such patients. The incidence of recur- 
rence of restenosis following Wiktor stent implantation 
in the first 50 consecutive patients has recently been 
published.tO The purpose of this study was to try to 
identify angiographic predictors of recurrence of reste- 
nosis after Wiktor stent implantation. This may not only 
have important clinical consequences, but may also 
broaden our understanding of the pathophysiology of 
restenosis. 
MRHODS 
PatienW Between January 1990 and May 1992, 
Wiktor stent implantation was attempted in 193 patients 
because of recurrence of angina due to restenosis of a 
native coronary artery lesion after previous balloon an- 
gioplasty. The study population consisted of 91 of the 
109 consecutive patients with successful stent implanta- 
tion without clinical evidence of thrombotic stent occlu- 
sion during hospital stay and in whom the scheduled fol- 
low-up angiography was completed at 5.7 Ifr 1.9 months 
(mean + SD) (Figure 1). 
Eighty-one patients were men (89%); the mean age 
(& SD) was 58 f 11 years. A first restenosis was docu- 
mented in 50 patients (55%), a second in 32 patients 
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TABLE I Findings at Quantitative Angiography After Wiktor Stent Implantation (n = 91 
patients) 
Before After After Stent 
PTCA PTCA Implantation At Follow-Up 
Reference diameter (mm) 2.85 k 0.49 2.80 2 0.48 3.02 2 0.42 2.98 f 0.47 
Minimal luminal diameter (mm) 1.13 -c 0.36 1.77 5 0.36 2.45 + 0.34 1.73 + 0.67 
Diameter stenosis (%) 60 2 10 35211 19 2 7 42 2 21 
All parameters are expressed as mean k SD. 
All changes were highly significant (p <O.OOOOl) except for the reference diameter; only the difference in reference 
diameter after stent implantation and after percutaneous transluminal coronary angioplasty was statistically significant 
(p <O.OOl). 
PTCA = percutaneous translummal coronary angioplasty. 
(35%), a third in 8 patients (9%) and a fourth in one 
other patient (1%). In all patients, a single Wiktor stent 
was implanted except in one, in whom a single stent was 
implanted in both the left anterior descending and the 
right coronary artery. The target vessel was the left an- 
terior descending artery in 48 patients (52%), the right 
coronary artery in 31 patients (34%), and the left cir- 
cumflex in 12 patients (13%). In another patient (l%), a 
single Wiktor stent was implanted in the left main stem. 
The size of the stent used was 3.4 + 0.4 mm (mean f 
SD): a 3.0 mm device in 38 patients (41%), a 3.5 mm 
device in 40 patients (44%) and a 4.0 mm device in 14 
patients (15%). The stent is described in detail elsewhere 
as well as the associated rug protocoL1t 
wk vmWks and d&WKom of restene 
sisr Based on the quantitative angiographic data, multi- 
ple variables were identified and recorded for each 
lesion. These variables were of a priori clinical interest 
on the basis of previously published reports on balloon 
angioplasty and intracoronaty stenting and of a more 
fundamental scientific interest based on experimental 
studies on stent implantation in animals.4J2-16 The fol- 
lowing continuous variables were selected: obstruction 
diameter before and immediately after stent implanta- 
tion, baseline reference diameter and diameter stenosis, 
length of target lesion, plaque area and the relative gain 
defined by the increase in minimal luminal diameter 
immediately after stent implantation ormalized to the 
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vessel size. In addition to these continuous variables, 
one discrete variable (left anterior descending artery) 
was selected. All coronary angiograms were analyzed 
with the computer-assisted Cardiovascular Angiography 
Analysis System. Its principles and deft&ions of angio- 
graphic variables has been described in a previous study 
on Wiktor stent implantation.11 Since the primary objec- 
tive of this study was to identify angiographic variables 
predicting restenosis, the process of restenosis was di- 
chotomized and delined according to the 0.72 mm and 
50% diameter stenosis criteria.17 
staU&ks A relative risk analysis was performed 
for the aforementioned angiographic variables. To avoid 
an arbitrary subdivision of data in the continuous vari- 
ables, the median value was chosen as cutoff point. The 
selection of this value as cutoff point has the advantage 
of being consistent for all values, and thus avoids any 
bias in the selection of subgroups that might be under- 
taken to emphasize a particular point. All values are 
expressed as mean f SD. The risk for restenosis for each 
parameter according to the 0.72 mm and 50% diameter 
stenosis criteria was determined by using an univariate 
analysis and is expressed as odds ratio with corre- 
sponding 95% confidence interval. An odds ratio of 1.0 
for a particular variable implies that the presence of that 
variable poses no additional risk for restenosis, an odds 
ratio >l.O or cl.0 implies additional or reduction in risk. 
Furthermore, since experimental animal data indicate 
that there is a relation between the severity of vessel 
wall injury and the extent of subsequent neointimal 
thickening, the relation between relative gain (as index 
of vessel wall injury) and relative loss (as index of neo- 
intimal thickening) was studied using a regression anal- 
ysis. The relative gain is previously defined. The rela- 
tive loss is the difference between the minimal luminal 
diameter immediately after stent implantation and at fol- 
low-up normalized to the vessel size. 
RESULTS 
hcidmce d restamh The changes in stenosis ge- 
ometry are summarized in Table I. The incidence of 
restenosis was 44% (40 of 91 patients) according to the 
0.72 mm criterion and 30% (27 of 91 patients) accord- 
ing to the 50% diameter stenosis criterion. When the 
stent is used as a unit, the incidence of restenosis was 
45% (41 of the 92 stents) and 29% (27 of the 92 sterns), 
respectively (Figure 2). 
WC predictors: The relative risk and 95% 
confidence intervals for each variable using either of the 
166 THE AMERICAN JOURNAL OF CARDIOLOGY VOLUME 72 JULY 15,1993 
TABLE II Angiographic Predictors of Restenosis After Wiktor Stent Implantation 
Restenosis Criteria 
Angiographic Variable 
0.72 mm 
Criterion 
50% Diameter 
Stenosis Criterion 
Relative gain (mm) 
Minimal luminal diameter after (mm) 
Minimal luminal diameter before (mm) 
Lesion length (mm) 
Reference diameter before (mm) 
Plaque area (mm*) 
Diameter stenosis before (%) 
Left anterior descending artery 
20.48 2.7 (1.1-6.4) 
22.38 1.8 (0.8-4.2) 
11.08 1.6 (0.7-3.7) 
2 6.48 1.4 (0.6-3.2) 
~2.77 1.3 (0.6-2.9) 
2 7.47 1.3 (0.6-2.9) 
261 1.0 (0.4-2.3) 
0.7 (0.3-1.7) 
1.1 (0.4-2.7) 
0.5 (0.2-1.4) 
2.7 (1.0-7.2) 
1.8 (0.7-4.6) 
1.4 (0.5-3.4) 
1.1 (0.4-2.7) 
1.3 (0.5-3.2) 
1.1 (0.5-2.8) 
2 criteria are listed in Table II. The only statistically sig- 
nilicant predictor of recurrence of restenosis according 
to the 0.72 mm criterion was the relative gain when it 
exceeded 0.48 (odds ratio 2.7, 95% confidence interval 
1.1-6.4). Related to the relative gain is the obstruction 
diameter before and after stent implantation. Although 
their odds ratio exceeds 1.0, their corresponding 95% 
confidence interval precludes any ti conclusion. The 
same holds for lesion length, reference diameter and 
plaque area. The left anterior descending artery was not 
identified as a risk factor for recurrence of restenosis. 
When using the 50% diameter stenosis criterion, no an- 
giographic predictor of restenosis was evident. 
The number of balloon angioplasties performed be- 
fore stent implantation did not influence the risk for sub- 
4 
MLD F/U (mm) 
jc CHRON OCCL: 4(4%) 
// 
1 I ? 50%: 27(29%Y / , 
4 
0.72 mm LONQ TERM WU?IARILITY 
0 I 1 2 3 MLD POST-STENT(mm) 
FlGuRE2.chmgesinthemhimdlllmind-(MU))at 
fohwp(F/U)aftewWihtorstentbnphbth.7hediame 
terofeachse#nentimmdbMyaftershtimplmRa&nis 
mcrcdnd- cEmnderatfel~p.Thelinesoneadl 
sidaafthsnnaafmnfRy(~)~twisetha 
ViwiabilRy (OS% coddmca bntarval) of duplkata nlsasucB 
mants (a chmge of to.72 mm). A si@Mcmt tbcmass in 
nlinimalundnd- acxod~!tothe~O.72nuncdteuh 
wasfoundin4leftha92stwtsi@mIted(4s%).The~ 
dSIlC8Of-S~llgtOthSSO%-~S 
cdtdonwas29%(27ofthe92stents).Ofth8se,4stents 
W-M oc&dedatfol~p,~shownonthex 
dS.-OCCL=ClStWlkOCdUdan. 
sequent restenosis after stenting. The odds for restenosis 
in case of stent implantation for a second, third or fourth 
restenosis compared with stent implantation for a lirst 
restenosis was 0.8 (95% contidence interval 0.4-1.8) 
according to the 0.72 mm criterion and was 1.5 (95% 
cotidence 0.6-3.7) according to the 50% diameter 
stenosis criterion. 
Regression analysis: The relation between relative 
gain, as index of vessel wall injury, and relative loss, as 
index of late neointimal hyperplasia s vessel wall re- 
sponse to injury, is shown in Figure 3. A Pearson prod- 
uct-moment correlation coefficient of 0.38 was found (p 
<O.OOl, slope 0.61, intercept -0.06). 
DISCUSSION 
The primary objective of this study was not the de- 
termination of the incidence of recurrent restenosis after 
Wiktor stent implantation in patients with restenosis af- 
ter previous balloon angioplasty. However, it is notewor- 
thy that the incidence of poststent restenosis reported 
here in the 91 patients is identical to the incidence of 
recurrent restenosis in the tist 50 consecutive patients.‘O 
Detailed analysis of a subgroup of 74 patients revealed 
that there was no late compression of the stent itself. 
, .4 Relative loss 
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Therefore, late loss or restenosis was due to ingrowth of 
tissue into the lumen of the stented segment.t8 
The lack of randomized studies precludes any con- 
clusion as to whether stent implantation i  this subset of 
patients will reduce the incidence of subsequent resteno- 
sis. Moreover, the exact incidence of recurrent resteno- 
sis after repeat balloon angioplasty is not known. There 
is some evidence that it increases with the number of 
repeat angioplasties. A second restenosis has been re- 
ported to occur in 25 and 34%, but amounts to 39 and 
40% after a third or fourth angioplasty, respectively.~9 
These data should be interpreted with caution consider- 
ing the difference between the study populations, the dif- 
ference in definition of restenosis, and in the time and 
completeness of follow-up angiography. In the present 
study in which stems were implanted because of reste- 
nosis, the risk for recurrent restenosis alter stenting did 
not differ between patients with a first restenosis and 
patients with a second, third or fourth restenosis. Two 
other studies failed to show a statistically sign&ant dif- 
ference in the restenosis rate for primary or de novo 
lesions compared with lesions that had undergone previ- 
ous balloon angioplasty. 12,13 However, subgroup analy- 
sis of patients in whom a single Palmaz-Schatz stent was 
implanted showed a restenosis rate of 13% compared 
with 36% for patients with previous restenosis.*3 
-0.2 
O0 
-0.4 
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stent/artery ratio 
The development of restenosis remains incompletely 
understood. Histologic data have shown that any injury 
to the vessel wall, whatever its nature, will invariably be 
associated with neointimal hyperplasia s a nonspecilic 
tissue response leading to restenosis when exces- 
sive.14J9-23 It is of both scientitic and utmost clinical 
importance to know and understand its development and 
to know the factors controlling the extent of the vessel 
wall response following injury. Experimental animal 
studies, postmortem pathologic observations in humans 
and angiographic studies have shown that the extent of 
neointimal hyperplasia is proportional to the degree of 
injury applied to the vessel wall (Figure 4).t4-16J4 This 
is in accord with earlier work in the porcine model, 
describing a relation between the degree of injury and 
early platelet deposition.25~26 In the present study, the rel- 
ative gain was used as angiographic orrelate of vessel 
wall injury. This parameter was found to be the only sta- 
tisticahy signilicant predictor of recurrence of restenosis 
when using the 0.72 mm criterion. The drawback of the . _._ ApesRivelhemmlatienwasfeundwRha~cadi 
fhnt(R)ofO.SS@eO.OO2)wRhadopeof0.6OtmnJan latter is, lirst, that the process of restenosis is dichot- 
ilMNqRof9~. omized (present/not present) and second, that although 
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statistically justifiable, cutoff points are used for the 
angiogmphic variables under investigation. However, the 
continuous approach underscores these Iindings by indi- 
cating a positive linear relation between the relative gain 
and relative loss. These observations were still valid 
when using absolute measurements. However, the cor- 
relation between the absolute gain and absolute loss was 
somewhat weaker (r = 0.21, p = 0.05). This is explained 
by the fact that the use of absolute values does not relate 
these changes to the vessel size. Although we found no 
difference in absolute loss between small and large ves- 
sels, an identical oss in minimal luminal diameter ep- 
resents a larger relative loss in a small vessel than in a 
large vessel, and vice versa. This conlirms other studies 
using a categorical approach to detine restenosis after 
stenting, that small vessels are not, per se, more prone 
to restenosis than large vessels.12J3,27 
This concept, describing a proportional relation be- 
tween vessel wall injury and neointimal thickening, has 
been reported in other studies using quantitative coro- 
nary angiography. Beatt et ali6 found that restenosis 
(0.72 mm criterion) was signilicantly correlated with 
both a greater improvement in obstruction diameter and 
a larger absolute dimension aher balloon angioplasty. 
Furthermore, in a recent study,28 the absolute change in 
minimal luminal diameter was reported to be the great- 
est single determinant of late luminal narrowing after 
balloon angioplasty. In another rep~rt?~ it was found 
that interventions achieving a “bigger” lumen provoke 
a concomitantly larger relative loss, so that the ultimate 
end point of various treatment methods is similar. 
All these findings carry potential far-reaching clini- 
cal implications. Clearly the greater the improvement in
minimal luminal diameter achieved by intervention, the 
greater the magnitude of subsequent luminal narrowing 
will be. Unfortunately, what cannot be extrapolated from 
the data is how much damage the clinician may intlict 
on the vessel wall. On the one hand, a suboptimal angio- 
graphic result is associated with a higher risk of suba- 
cute occlusion due to rheologic factors and platelet 
deposition and a higher need for repeat balloon angio- 
plasty but, on the other hand, improvement of the initial 
result may be at the price of more extensive late neoin- 
timal thickening.i4i6*30,31 This indistinctness can be cir- 
cumvented by properly matching the balloon size or 
device with the vessel wall using on-line quantitative 
coronary angiography. This is underscored by the data 
displayed in Figure 5 indicating that the more the stent 
is oversized, the greater the loss in minimal luminal di- 
ameter will be. 
So far, there are 2 other angiographic studies that 
have attempted to identify risk factors for restenosis or 
recurrence of restenosis, and they found, as in the pres- 
ent study, that the vessel size and severity of stenosis, 
expressed as diameter stenosis and length of the lesion, 
not to be associated with an increased risk for resteno- 
sis.r2J3 As mentioned, the indication (primary or secon- 
dary stenting) was not associated with an increased risk 
for restenosis.12J3 In accordance with these 2 studies on 
stenting and 1 other study on balloon angioplasty, the 
target vessel was not associated with an increased risk 
for (recurrent) restenosis.12J3.32 
SW limitations: The study limitations are essen- 
tially twofold. First, the precision of relative gain as an 
angiographic ndex of vessel wall injury and relative loss 
as an index of neointimal hyperplasia has not been stud- 
ied. The coronary angiogram is a 2dirnensional echo- 
cardiogram describing the changes in stenosis geometry 
but not the nature or extent of the pathology explaining 
these angiographic hanges. Therefore, the measurement 
of the minimal luminal diameter, and consequently the 
relative gain and loss, are subject to potential im- 
precision. Second, the effect of other clinical, procedu- 
ral and lesion-related characteristics on the development 
of late neointimal hyperplasia has not been considered. 
It is conceivable that if these characteristics play a role 
in the pathogenesis of neointimal thickening, they may 
not be uniformly distributed over the study population. 
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